These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7059415)

  • 21. Pharmacokinetics of triclabendazole in rabbits.
    Alvarez-Bujidos ML; Ortiz AI; Negro A; Cubría JC; Ordóñez D
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Nov; 106(3):805-8. PubMed ID: 7905812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assay of sulphinpyrazone in plasma and urine by high-performance liquid chromatography.
    Lecaillon JB; Souppart C
    J Chromatogr; 1976 Jun; 121(2):227-34. PubMed ID: 932142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reduction of sulphinpyrazone and sulindac by intestinal bacteria.
    Strong HA; Renwick AG; George CF; Liu YF; Hill MJ
    Xenobiotica; 1987 Jun; 17(6):685-96. PubMed ID: 3630204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatographic determination of sulfinpyrazone and its metabolites in plasma.
    Kuo BS; Kaplan LA; Ritschel WA
    Arzneimittelforschung; 1984; 34(5):548-50. PubMed ID: 6540568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the gut flora in the reduction of sulfinpyrazone in humans.
    Strong HA; Oates J; Sembi J; Renwick AG; George CF
    J Pharmacol Exp Ther; 1984 Sep; 230(3):726-32. PubMed ID: 6470977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Verapamil disposition--effects of sulphinpyrazone and cimetidine.
    Wing LM; Miners JO; Lillywhite KJ
    Br J Clin Pharmacol; 1985 Mar; 19(3):385-91. PubMed ID: 3986090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formation following dermal application to human volunteers.
    Timchalk C; Selim S; Sangha G; Bartels MJ
    Hum Exp Toxicol; 1998 Aug; 17(8):411-7. PubMed ID: 9756132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of sulfinpyrazone and four metabolites in plasma and urine by high pressure liquid chromatography.
    Lentjes EG; Tan Y; Van Ginneken CA
    Pharm Weekbl Sci; 1985 Dec; 7(6):252-9. PubMed ID: 4080510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of lansoprazole.
    Landes BD; Petite JP; Flouvat B
    Clin Pharmacokinet; 1995 Jun; 28(6):458-70. PubMed ID: 7656504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sulphinpyrazone (Anturan) on uric acid excretion and plasma uric acid concentration in healthy volunteers.
    Pfister B; Imhof P; Wirz H
    Eur J Clin Pharmacol; 1978 Jun; 13(4):263-5. PubMed ID: 668783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers.
    Wong SL; Awni WM; Cavanaugh JH; el-Shourbagy T; Locke CS; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():9-21. PubMed ID: 8620676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and metabolism of 14C-tinidazole in humans.
    Wood SG; John BA; Chasseaud LF; Brodie RR; Baker JM; Faulkner JK; Wood BA; Darragh A; Lambe RF
    J Antimicrob Chemother; 1986 Jun; 17(6):801-9. PubMed ID: 3733593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.
    Hümpel M; Krause W; Hoyer GA; Wendt H; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):347-57. PubMed ID: 6532807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the sulphoxides and sulphones of three simple sulphides in rat urine: effects of phenobarbitone, beta-naphthoflavone and methimazole.
    Nnane IP; Damani LA
    Biomed Chromatogr; 2005 Jan; 19(1):87-98. PubMed ID: 15470701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
    He M; Kunze KL; Trager WF
    Drug Metab Dispos; 1995 Jun; 23(6):659-63. PubMed ID: 7587949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
    Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 May; 15(5):567-9. PubMed ID: 6860533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.